[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Gastrointestinal Stromal Tumor Molecular Diagnostics Market - Global Outlook and Forecast 2021-2027

April 2021 | 90 pages | ID: G47AA4D4463BEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Gastrointestinal Stromal Tumor Molecular Diagnostics in Global, including the following market information:

Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Gastrointestinal Stromal Tumor Molecular Diagnostics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gastrointestinal Stromal Tumor Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Segment Percentages, By Type, 2020 (%)
  • PCR
  • FISH
  • DNA Sequencing
  • Gene Chip
China Gastrointestinal Stromal Tumor Molecular Diagnostics Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Segment Percentages, By Application, 2020 (%)
  • Clinical Diagnosis
  • Drug Screening
  • Research
Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Gastrointestinal Stromal Tumor Molecular Diagnostics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Gastrointestinal Stromal Tumor Molecular Diagnostics Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Yin Feng Gene
  • KingMed
  • Geneis
  • Haplox
  • AmoyDX
  • Admera
  • GeneChem
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GASTROINTESTINAL STROMAL TUMOR MOLECULAR DIAGNOSTICS OVERALL MARKET SIZE

2.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size: 2021 VS 2027
2.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players in Global Market
3.2 Top Global Gastrointestinal Stromal Tumor Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Gastrointestinal Stromal Tumor Molecular Diagnostics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Gastrointestinal Stromal Tumor Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gastrointestinal Stromal Tumor Molecular Diagnostics Players in Global Market
  3.6.1 List of Global Tier 1 Gastrointestinal Stromal Tumor Molecular Diagnostics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Gastrointestinal Stromal Tumor Molecular Diagnostics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Markets, 2021 & 2027
  4.1.2 PCR
  4.1.3 FISH
  4.1.4 DNA Sequencing
  4.1.5 Gene Chip
4.2 By Type - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue & Forecasts
  4.2.1 By Type - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2016-2021
  4.2.2 By Type - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2022-2027
  4.2.3 By Type - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2021 & 2027
  5.1.2 Clinical Diagnosis
  5.1.3 Drug Screening
  5.1.4 Research
5.2 By Application - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue & Forecasts
  5.2.1 By Application - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2016-2021
  5.2.2 By Application - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2022-2027
  5.2.3 By Application - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2021 & 2027
6.2 By Region - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue & Forecasts
  6.2.1 By Region - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2016-2021
  6.2.2 By Region - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2022-2027
  6.2.3 By Region - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2016-2027
  6.3.2 US Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2016-2027
  6.3.3 Canada Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2016-2027
  6.3.4 Mexico Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2016-2027
  6.4.2 Germany Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2016-2027
  6.4.3 France Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2016-2027
  6.4.4 U.K. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2016-2027
  6.4.5 Italy Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2016-2027
  6.4.6 Russia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2016-2027
  6.4.7 Nordic Countries Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2016-2027
  6.4.8 Benelux Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2016-2027
  6.5.2 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2016-2027
  6.5.3 Japan Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2016-2027
  6.5.4 South Korea Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2016-2027
  6.5.5 Southeast Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2016-2027
  6.5.6 India Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2016-2027
  6.6.2 Brazil Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2016-2027
  6.6.3 Argentina Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2016-2027
  6.7.2 Turkey Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2016-2027
  6.7.3 Israel Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2016-2027
  6.7.4 Saudi Arabia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2016-2027
  6.7.5 UAE Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Yin Feng Gene
  7.1.1 Yin Feng Gene Corporate Summary
  7.1.2 Yin Feng Gene Business Overview
  7.1.3 Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Major Product Offerings
  7.1.4 Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global (2016-2021)
  7.1.5 Yin Feng Gene Key News
7.2 KingMed
  7.2.1 KingMed Corporate Summary
  7.2.2 KingMed Business Overview
  7.2.3 KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Major Product Offerings
  7.2.4 KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global (2016-2021)
  7.2.5 KingMed Key News
7.3 Geneis
  7.3.1 Geneis Corporate Summary
  7.3.2 Geneis Business Overview
  7.3.3 Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Major Product Offerings
  7.3.4 Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global (2016-2021)
  7.3.5 Geneis Key News
7.4 Haplox
  7.4.1 Haplox Corporate Summary
  7.4.2 Haplox Business Overview
  7.4.3 Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Major Product Offerings
  7.4.4 Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global (2016-2021)
  7.4.5 Haplox Key News
7.5 AmoyDX
  7.5.1 AmoyDX Corporate Summary
  7.5.2 AmoyDX Business Overview
  7.5.3 AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Major Product Offerings
  7.5.4 AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global (2016-2021)
  7.5.5 AmoyDX Key News
7.6 Admera
  7.6.1 Admera Corporate Summary
  7.6.2 Admera Business Overview
  7.6.3 Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Major Product Offerings
  7.6.4 Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global (2016-2021)
  7.6.5 Admera Key News
7.7 GeneChem
  7.7.1 GeneChem Corporate Summary
  7.7.2 GeneChem Business Overview
  7.7.3 GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Major Product Offerings
  7.4.4 GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global (2016-2021)
  7.7.5 GeneChem Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Drivers in Global Market
Table 3. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of Gastrointestinal Stromal Tumor Molecular Diagnostics in Global Market
Table 5. Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Gastrointestinal Stromal Tumor Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 Gastrointestinal Stromal Tumor Molecular Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastrointestinal Stromal Tumor Molecular Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 30. Yin Feng Gene Corporate Summary
Table 31. Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Product Offerings
Table 32. Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 33. KingMed Corporate Summary
Table 34. KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Product Offerings
Table 35. KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 36. Geneis Corporate Summary
Table 37. Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Product Offerings
Table 38. Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 39. Haplox Corporate Summary
Table 40. Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Product Offerings
Table 41. Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 42. AmoyDX Corporate Summary
Table 43. AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Product Offerings
Table 44. AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 45. Admera Corporate Summary
Table 46. Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Product Offerings
Table 47. Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 48. GeneChem Corporate Summary
Table 49. GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Product Offerings
Table 50. GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Gastrointestinal Stromal Tumor Molecular Diagnostics Segment by Type
Figure 2. Gastrointestinal Stromal Tumor Molecular Diagnostics Segment by Application
Figure 3. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in 2020
Figure 8. By Type - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 12. US Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 16. Germany Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 17. France Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 24. China Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 28. India Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 30. Brazil Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 33. Turkey Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 37. Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications